Santen Pharmaceutical Co., Ltd.
OTC: SNPHY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Takeshi Ito
- Employees
- 3,744
- Headquarters
- Osaka, Japan
- IPO year
- 2011
- Market cap
- $4.0B
- Website
- https://www.santen.com
Loading SNPHY…
Loading profile data…Frequently asked questions about SNPHY
What does Santen Pharmaceutical Co., Ltd. (SNPHY) do?
Santen Pharmaceutical Co., Ltd. is a global enterprise dedicated to the research, development, manufacturing, and distribution of pharmaceuticals and medical devices, with operations spanning Japan and international markets. The company maintains a significant pipeline and array of products focused on ophthalmic conditions. For glaucoma and ocul...
Where does SNPHY trade?
Santen Pharmaceutical Co., Ltd. (SNPHY) trades on the Other OTC.
What sector is SNPHY in?
Santen Pharmaceutical Co., Ltd. (SNPHY) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Santen Pharmaceutical Co., Ltd.?
Takeshi Ito is the chief executive officer of Santen Pharmaceutical Co., Ltd. (SNPHY).
Where is Santen Pharmaceutical Co., Ltd. headquartered?
Santen Pharmaceutical Co., Ltd. is headquartered in Japan.
Does SNPHY pay a dividend?
Yes — Santen Pharmaceutical Co., Ltd. (SNPHY) paid a trailing twelve-month dividend of USD 0.22 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SNPHY go public?
Santen Pharmaceutical Co., Ltd. (SNPHY) completed its initial public offering in 2011.
Is SNPHY an ADR?
Yes — SNPHY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Santen Pharmaceutical Co., Ltd. reporting and dividends follow the underlying issuer.